Dimensional U.S. Targeted Value ETF (DFAT) seeks to provide investment results that correspond to the performance of U.S. companies identified as value stocks using Dimensional's proprietary research-based approach. This strategy targets companies trading at low prices relative to their book value, emphasizing small-cap and mid-cap value stocks often overlooked by traditional value indices.
How It Works
DFAT employs Dimensional's evidence-based investment approach, using multiple valuation metrics including price-to-book ratios, profitability measures, and investment patterns to identify undervalued companies. The fund actively weights holdings based on these value characteristics rather than market capitalization, with higher allocations to companies exhibiting stronger value signals. Portfolio construction integrates academic research on market anomalies, with quarterly rebalancing to maintain target exposures while managing transaction costs through patient trading strategies.
Key Features
- Applies Dimensional's 50+ years of academic research to target value premiums beyond simple price-to-book screening methods
- Emphasizes small-cap and mid-cap value stocks that typically offer higher expected returns than large-cap value alternatives
- Zero expense ratio makes it one of the most cost-effective ways to access sophisticated factor-based value investing strategies
Risks
- This ETF can lose significant value during growth stock rallies when investors favor momentum over value, potentially underperforming for multi-year periods like 2017-2020
- Small-cap and mid-cap focus creates higher volatility than large-cap value funds, with potential for 40-50% declines during severe market downturns
- Value investing can experience prolonged periods of underperformance as market preferences shift toward growth stocks, testing investor patience and discipline
Who Should Own This
Best suited for sophisticated investors with 7+ year time horizons and high risk tolerance who understand factor investing principles. Works as a satellite holding (10-25% of equity allocation) complementing core market exposure. Requires patience during inevitable periods of value underperformance and belief in long-term academic research supporting value premiums.